Tyche Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$479K Sell
5,619
-184
-3% -$16.4K 0.07% 204
2025
Q4
$459K Buy
5,803
+59
+1% +$4.63K 0.07% 202
2025
Q3
$459K Sell
5,744
-150
-3% -$12.8K 0.08% 171
2025
Q2
$536K Hold
5,894
0.11% 143
2025
Q1
$552K Sell
5,894
-1,046
-15% -$93.7K 0.12% 125
2024
Q4
$631K Buy
6,940
+876
+14% +$83.6K 0.13% 132
2024
Q3
$630K Sell
6,064
-352
-5% -$35.9K 0.14% 106
2024
Q2
$623K Sell
6,416
-1,008
-14% -$93K 0.15% 107
2024
Q1
$669K Sell
7,424
-1,917
-21% -$162K 0.16% 106
2023
Q4
$745K Buy
+9,341
New +$702K 0.18% 106

Other funds holding CL

Tyche Wealth Partners's CL Position: Q1 2026 in Review

Tyche Wealth Partners reduced its Colgate-Palmolive (CL) stake by 3.2% in Q1 2026, selling an estimated $16.4K and leaving 5,619 shares worth $479K. The position accounts for 0.07% of the portfolio, ranked #204.

Tyche Wealth Partners first reported a position in CL in Q4 2023 and has held it in 10 quarters since. The position peaked at $745K in Q4 2023. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Tyche Wealth Partners held 5,619 shares of Colgate-Palmolive worth $479K as of Q1 2026.
  • Tyche Wealth Partners sold 184 Colgate-Palmolive shares in Q1 2026, an estimated $16.4K.
  • Colgate-Palmolive made up 0.07% of Tyche Wealth Partners's portfolio in Q1 2026, its #204 holding.
  • Tyche Wealth Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 10 quarters since.
  • Tyche Wealth Partners's Colgate-Palmolive position peaked at $745K in Q4 2023.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Tyche Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.